Its not fully understood how these receptor agonists cause weight loss, but we know that GLP-1 reduces hunger and slows digestion, so they may make you feel fuller longer
This exclusion means Wegovy is not covered regardless of medical necessity, doctor recommendation, or obesity severity
You can learn more about how to do an elimination diet in my article here
Check the tier
Novo says the breadth of the advertising campaign is causing competitive harm and the false superiority messages are reaching a large, ever-growing audience of prospective patients. Novo Nordisk Says Lillys Ad Is No Longer Accurate Novo Nordisks lawsuit cites a study that shows its higher 7.2 milligram dose of Wegovy, approved by the FDA in March, helps patients lose an average of 47 pounds, while one in three participants lost about 62 pounds
Aftercare & Follow-Ups: After numerous classes, changes in the form will be noticeable